Schedule 13G ownership disclosure

LENZ THERAPEUTICS INC

Common Stock, $0.00001 par value per share · CUSIP: 52635N103

Event date: 2026-11-02

Filing-level shares
2,110,727
Percent of class
6.7%
  • BML Investment Partners, L.P.

    Shares: 2,110,727 · Class: 6.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001373604-26-000076
Form type
SCHEDULE 13G
Filer
LENZ Therapeutics, Inc.
CIK
CIK 1815776
Filed
Nov 04, 2026
Reporting period
Nov 02, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub